Experts Warn Of Escalating Antimicrobial Resistance Threat In India
Data suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by 2050
Antimicrobial resistance (AMR) poses a significant and growing threat in India, as highlighted during EuroAsia 2024 by leading critical care specialists. The experts stressed the urgent need for a comprehensive 'One Health' approach to combat this global challenge.
During the conference, Bharat Jagiasi, Pradip Bhattacharya, Srinivas Samavedam, Pradeep Rangappa, Rajesh Pande, Sachin Gupta, Bhuvana Krishna, and Kartik Rao underscored the critical importance of enhancing antimicrobial stewardship across healthcare sectors. They stressed the implementation of robust surveillance systems, effective antibiotic stewardship, and stringent infection prevention measures to mitigate the spread of drug-resistant bacteria, often referred to as "superbugs."
Speaking to the media, Bharat Jagiasi, General Secretary of ISCCM, emphasised the detrimental impact of AMR on healthcare outcomes, citing prolonged hospital stays and increased mortality rates. He called for intensified public awareness campaigns and improved hygiene practices to prevent infections and minimise the repercussions of AMR.
Prof. Pradip Bhattacharya, President of ISCCM, expressed concern over the alarming number of deaths attributed to AMR in India, estimating 1.2 million fatalities already and projecting up to 10 million deaths by 2050 if current trends persist. He stressed the urgent need for stringent regulation of antibiotic use and the promotion of judicious prescribing practices.
Srinivas Samavedam, President-Elect of ISCCM, highlighted the collaborative efforts needed across stakeholders to effectively manage AMR. He emphasised the importance of building trust between patients and healthcare providers to optimise antibiotic therapy and improve treatment outcomes.
Pradeep Rangappa, former Secretary of ISCCM, echoed concerns over the excessive and inappropriate use of antibiotics in India. He called for the implementation of national action plans and surveillance guidelines to monitor resistance patterns and mitigate the spread of resistant bacteria.
Rajesh Pande, principal Director at BLK MAX Super Specialty Hospital, emphasised the critical role of pharmaceutical innovation in combating AMR. He urged pharmaceutical companies to develop new anti-infectives to address the growing challenge of drug-resistant pathogens effectively.
